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What is Marburg hemorrhagic fever? 
Marburg hemorrhagic fever (Marburg HF) is a rare, severe type of 
hemorrhagic fever which affects both humans and non-human 
primates. Caused by a genetically unique zoonotic (that is, 
animal-borne) RNA virus of the filovirus family, its recognition led 
to the creation of this virus family. The five subtypes of Ebola virus 
are the only other known members of the filovirus family. 
 
Marburg virus was first recognized in 1967, when outbreaks of 
hemorrhagic fever occurred simultaneously in laboratories in 
Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia 
(now Serbia). A total of 31 people became ill; they included 
laboratory workers as well as several medical personnel and 
family members who had cared for them. There were 7 deaths 
among the reported cases. The first people infected had been 
exposed to African green monkeys or their tissues. In Marburg, 
the monkeys had been imported for research and to prepare polio 
vaccine. In addition to the 31 cases, an additional primary case 





Where is Marburg virus found nature? 
 
Recent scientific studies implicate the African fruit bat (Rousettus aegyptiacus) as the reservoir host of the 
Marburg virus. The African fruit bat is a sighted, cave-dwelling bat which is widely distributed across Africa. Fruit 
bats infected with Marburg virus do not to show obvious signs of illness. Primates, including humans, can 
become infected with Marburg virus, which can progress to serious disease with high mortality. Further study is 
needed to determine if other species may also host the virus. Given the fruit bat’s wide distribution, more areas 
are at risk for outbreaks of Marburg HF than previously suspected. The virus is not known to be native to other 




Where do cases of Marburg hemorrhagic fever occur? 
Confirmed cases of Marburg HF have been reported in Uganda, Zimbabwe, the Democratic Republic of the 
Congo, Kenya, and Angola. Cases of Marburg HF have occurred outside Africa, though infrequently. The first 
confirmed cases of Marburg HF were recognized among laboratory workers and hospital staff in Germany and 
Yugoslavia. In 2008, a Dutch tourist developed Marburg HF after returning to the Netherlands from Uganda, 
and subsequently died. Also in 2008, an American traveler developed Marburg HF after returning to the US 
from Uganda. Both travelers had visited a well-known cave inhabited by fruit bats in a national park. The 




Marburg HF typically appears in sporadic outbreaks throughout Africa. Many of the outbreaks have occurred 
among male mine workers with the virus transmitted throughout their communities by ways of cultural practices, 
under protected family care settings and under protected health staff. It is also possible that sporadic, isolated 
cases occur as well, but go unrecognized. A table showing the chronological list of known cases and outbreaks 
is available below. 
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How do humans get Marburg hemorrhagic fever? 
Just how the animal host first transmits Marburg virus to humans is unknown. However, as with some other 
viruses which cause viral hemorrhagic fever, humans who become ill with Marburg hemorrhagic fever may 
spread the virus to other people. This may happen in several ways. Persons who have handled infected 
monkeys and have come in direct contact with their fluids or cell cultures, have become infected. Spread of the 
virus between humans has occurred in a setting of close contact, often in a hospital. Droplets of body fluids, or 
direct contact with persons, equipment, or other objects contaminated with infectious blood or tissues are all 





What are the symptoms of the disease? 
After an incubation period of 5-10 days, the onset of the disease is sudden and is marked by fever, chills, 
headache, and myalgia. Around the fifth day after the onset of symptoms, a maculopapular rash, most 
prominent on the trunk (chest, back, stomach), may occur. Nausea, vomiting, chest pain, a sore throat, 
abdominal pain, and diarrhea then may appear. Symptoms become increasingly severe and may include 
jaundice, inflammation of the pancreas, severe weight loss, delirium, shock, liver failure, massive 
hemorrhaging, and multi-organ dysfunction. 
 
Because many of the signs and symptoms of Marburg hemorrhagic fever are similar to those of other infectious 
diseases, such as malaria or typhoid fever, diagnosis of the disease can be difficult, especially if only a single 
case is involved. 
 
Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing, IgM-capture ELISA, polymerase chain 
reaction (PCR), and virus isolation can be used to confirm a case of Marburg hemorrhagic fever within a few 
days of the onset of symptoms. The IgG-capture ELISA is appropriate for testing persons later in the course of 
disease or after recovery. The disease is readily diagnosed by immunohistochemistry, virus isolation, or PCR of 





Are there complications after recovery? 
Recovery from Marburg hemorrhagic fever may be prolonged and accompanied by orchitis, recurrent 
hepatitis, transverse myelitis or uveitis. Other possible complications include inflammation of the testis, spinal 





Is the disease ever fatal? 





How is Marburg hemorrhagic fever treated? 
A specific treatment for this disease is unknown. However, supportive hospital therapy should be utilized. This 
includes balancing the patient’s fluids and electrolytes, maintaining their oxygen status and blood pressure, 
replacing lost blood and clotting factors and treating them for any complicating infections. 
 
Sometimes treatment also has used transfusion of fresh-frozen plasma and other preparations to replace the 
blood proteins important in clotting. One controversial treatment is the use of heparin (which blocks clotting) to 
prevent the consumption of clotting factors. Some researchers believe the consumption of clotting factors is 
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Who is at risk for the illness? 
People who have close contact with a human or non-human primate infected with the virus are at risk. Such 
persons include laboratory or quarantine facility workers who handle non-human primates that have been 
associated with the disease. In addition, hospital staff and family members who care for patients with the 





How is Marburg hemorrhagic fever prevented? 
Due to our limited knowledge of the disease, preventive measures against transmission from the original 
animal host have not yet been established. Measures for prevention of secondary transmission are similar to 
those used for other hemorrhagic fevers. If a patient is either suspected or confirmed to have Marburg 
hemorrhagic fever, barrier nursing techniques should be used to prevent direct physical contact with the 
patient. These precautions include wearing of protective gowns, gloves, and masks; placing the infected 
individual in strict isolation; and sterilization or proper disposal of needles, equipment, and patient excretions. 
 
In conjunction with the World Health Organization, CDC has developed practical, hospital-based guidelines, 
titled: Infection Control for Viral Haemorrhagic Fevers In the African Health Care Setting. The manual can help 
health-care facilities recognize cases and prevent further hospital-based disease transmission using locally 





What needs to be done to address the threat of Marburg hemorrhagic fever? 
Marburg hemorrhagic fever is a very rare human disease. However, when it does occur, it has the potential to 
spread to other people, especially health care staff and family members who care for the patient. Therefore, 
increasing awareness among health-care providers of clinical symptoms in patients that suggest Marburg 
hemorrhagic fever is critical. Better awareness can help lead to taking precautions against the spread of virus 
infection to family members or health-care providers. Improving the use of diagnostic tools is another priority. 
With modern means of transportation that give access even to remote areas, it is possible to obtain rapid testing 
of samples in disease control centers equipped with Biosafety Level 4 laboratories in order to confirm or rule out 
Marburg virus infection. 
 
A fuller understanding of Marburg hemorrhagic fever will not be possible until the ecology and identity of the 
virus reservoir are established. In addition, the impact of the disease will remain unknown until the actual 
incidence of the disease and its endemic areas are determined. 
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Marburg Hemorrhagic Fever 
Known Cases and Outbreaks of Marburg Hemorrhagic Fever, in 
Chronological Order [Last updated April 23, 2012] 
 
 










1967 Germany and 
Yugoslavia 
Uganda 31 7 (23) Simultaneous outbreaks 
occurred in laboratory 
workers handling African 
green monkeys imported 
from Uganda [1a]. In 
addition to the 31 reported 
cases, an additional primary 





Zimbabwe 3 1 (33) A man with a recent travel 
history to Zimbabwe was 
admitted to hospital in 
South Africa. Infection 
spread from the man to his 
traveling companion and a 
nurse at the hospital. The 
man died, but both women 
were given vigorous 
supportive treatment and 
eventually recovered [2]. 
1980 Kenya Kenya 2 1 (50) Recent travel history 
included a visit to Kitum 
Cave in Kenya’s Mount 
Elgon National Park. 
Despite specialized care in 
Nairobi, the male patient 
died. A doctor who 
attempted resuscitation 
developed symptoms 9 
days later but recovered [3]. 
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1987 Kenya Kenya 1   1 (100) A 15-year-old Danish boy was 
hospitalized with a 3-day history 
of headache, malaise, fever, and 
vomiting. Nine days prior to 
symptom onset, he had visited 
Kitum Cave in Mount Elgon 
National Park. Despite 
aggressive supportive therapy, 
the patient died on the 11th day 






Durba, DRC 154 128 (83) Most cases occurred in young 
male workers at a gold mine in 
Durba, in the north-eastern part 
of the country, which proved to 
be the epicentre of the outbreak. 
Cases were subsequently 
detected in the neighboring 
village of Watsa [5]. 
2004-2005 Angola Uige Province, Angola 252 227 Outbreak believed to have 
begun in Uige Province in 
October 2004. Most cases 
detectedin other provinces 
have been linked directly to the 
outbreak in Uige [6]. 
2007 Uganda Lead and gold mine in 
Kamwenge District, 
Uganda 
2    2 (50) Small outbreak, with 2 
cases in young males 
working in a mine. To date, 
there have been no reported 




Cave in Maramagambo 
forest in Uganda, at the 
southern edge of Queen 
Elizabeth National Park. 
1    1 (100) A 40-year old Dutch woman 
with a recent history of travel to 
Uganda was admitted to a 
hospital in the Netherlands. 
Three days prior to 
hospitalization, the first 
symptoms (fever, chills) 
occurred, followed by rapid 
clinical deterioration. The 
woman died on the 10th day of 
the illness. [8] [9] 
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